Loading clinical trials...
Loading clinical trials...
The present study aims at assessing long-term hemostatic profile of patients recovered from COVID-19 acute infection that remain asymptomatic (POST-COVID) versus patients with residual symptoms (LONG-COVID) through the employment of a commercially available new generation point-of-care viscoelastic device. The primary endpoint is based upon the hypothesis that patients with residual symptoms maintain an abnormal coagulation profile even after recovery from COVID-19.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
IRCCS Policlinico San Donato
San Donato Milanese, MI, Italy
Start Date
April 12, 2022
Primary Completion Date
November 15, 2022
Completion Date
November 15, 2022
Last Updated
February 16, 2023
102
ACTUAL participants
ClotPro assessment
DIAGNOSTIC_TEST
Laboratory analysis
DIAGNOSTIC_TEST
Interview
OTHER
Lead Sponsor
IRCCS Policlinico S. Donato
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06631287